Progyny, Inc. (PGNY) Investor Relations Documents

Progyny, Inc. (PGNY) investor relations documents from the company's IR site: 6 presentations, 32 press releases; latest deck 2026-01-13. Read in-app with summaries. First-party data.

JP Morgan Conference Presentation: Progyny's January 2026 presentation highlights 5x client growth and 5.6x revenue CAGR (2019-2025), driven by superior cost management and member outcomes in fertility services.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-07Press releaseProgyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
2026-08-06Press releaseProgyny, Inc. Announces Second Quarter 2026 Results
2026-07-23Press releaseProgyny, Inc. Announces Details for Its Second Quarter 2026 Results Report
2026-05-28Press releaseNew Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System
2026-05-26Press releaseProgyny, Inc. Announces Share Repurchase Program
2026-05-11Press releaseProgyny, Inc. to Present at BofA Securities 2026 Health Care Conference
2026-05-07Press releaseProgyny, Inc. Announces First Quarter 2026 Results
2026-04-23Press releaseProgyny, Inc. Announces Details for Its First Quarter 2026 Results Report
2026-04-16Press releaseProgyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
2026-04-01Press releaseProgyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care
2026-03-06Press releaseRead More
2026-02-26Financial supplementQ4 2025 Earnings Supplement
Press releaseRead More
2026-02-12Press releaseRead More
2026-01-13PresentationJP Morgan Conference Presentation
2026-01-12Press releaseRead More
2025-11-20Press releaseRead More
Press releaseProgyny, Inc. Announces Third Quarter 2025 Results
Press releaseProgyny, Inc. Announces Second Quarter 2025 Results
Press releaseProgyny, Inc. Announces First Quarter 2025 Results
2025-02-27Press releaseProgyny, Inc. Announces Fourth Quarter 2024 Results
2025-01-14PresentationJP Morgan Conference Presentation
2024-11-12Press releaseProgyny, Inc. Announces Third Quarter 2024 Results
2024-08-15Regulatory report0000000000-24-009359.pdf
2024-08-11PresentationInvestor Day Presentation
2024-08-06Press releaseProgyny, Inc. Announces Second Quarter 2024 Results
2024-05-09Press releaseProgyny, Inc. Announces First Quarter 2024 Results
2024-02-27Press releaseProgyny, Inc. Announces Fourth Quarter 2023 Results
2024-01-08PresentationView Presentation
2023-11-07Press releaseProgyny, Inc. Announces Third Quarter 2023 Results
2023-08-03Press releaseProgyny, Inc. Announces Second Quarter 2023 Results
2023-05-08Press releaseProgyny, Inc. Announces First Quarter 2023 Results
2023-02-27Press releaseProgyny, Inc. Announces Fourth Quarter 2022 Results
2023-01-09PresentationJP Morgan Healthcare Conference Presentation
2022-11-03Press releaseProgyny, Inc. Announces Third Quarter 2022 Results
2022-08-04Press releaseProgyny, Inc. Announces Second Quarter 2022 Results
2022-05-05Press releaseProgyny, Inc. Announces First Quarter 2022 Results
2022-02-28Press releaseProgyny, Inc. Announces Fourth Quarter and Full Year 2021 Results
2022-01-10PresentationJ.P. Morgan 2022 Virtual Healthcare Conference Presentation
2021-11-04Press releaseProgyny, Inc. Announces Third Quarter 2021 Results

PGNY overview · PGNY earnings · PGNY financials · PGNY KPIs · PGNY documents · PGNY ownership · PGNY peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.